| TNF-α-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation E Rovida, A Paccagnini, M Del Rosso, J Peschon, P Dello Sbarba The Journal of Immunology 166 (3), 1583-1589, 2001 | 184 | 2001 |
| Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow‐repopulating ability together with the expansion of committed progenitors Ivanović, Bartolozzi, Bernabei, Cipolleschi, Rovida, Milenković, Praloran, ... British journal of haematology 108 (2), 424-429, 2000 | 134 | 2000 |
| Transmodulation of cell surface regulatory molecules via ectodomain shedding PD Sbarba, E Rovida Walter de Gruyter 383 (1), 69-83, 2002 | 109 | 2002 |
| ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells E Rovida, N Navari, A Caligiuri, PD Sbarba, F Marra Journal of hepatology 48 (1), 107-115, 2008 | 91 | 2008 |
| Impact of ERK5 on the Hallmarks of Cancer B Stecca, E Rovida International journal of molecular sciences 20 (6), 1426, 2019 | 90 | 2019 |
| The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma E Rovida, G Di Maira, I Tusa, S Cannito, C Paternostro, N Navari, E Vivoli, ... Gut 64 (9), 1454-1465, 2015 | 80 | 2015 |
| Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities? E Rovida, B Stecca Seminars in cancer biology 35, 154-167, 2015 | 78 | 2015 |
| Hypoxia suppresses BCR/Abl and selects imatinib-insensitive progenitors within clonal CML populations S Giuntoli, E Rovida, V Barbetti, MG Cipolleschi, M Olivotto, ... Leukemia 20 (7), 1291-1293, 2006 | 77 | 2006 |
| The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability MG Cipolleschi, E Rovida, Z Ivanovic, V Praloran, M Olivotto, ... Leukemia 14 (4), 735-739, 2000 | 77 | 2000 |
| ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion E Rovida, E Spinelli, S Sdelci, V Barbetti, A Morandi, S Giuntoli, ... The Journal of Immunology 180 (6), 4166-4172, 2008 | 76 | 2008 |
| Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine G Cheloni, M Tanturli, I Tusa, N Ho DeSouza, Y Shan, A Gozzini, ... Blood, The Journal of the American Society of Hematology 130 (5), 655-665, 2017 | 72 | 2017 |
| Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells S Cannito, C Turato, C Paternostro, A Biasiolo, S Colombatto, I Cambieri, ... Oncotarget 6 (4), 2206, 2015 | 72 | 2015 |
| ERK5 is activated by oncogenic BRAF and promotes melanoma growth I Tusa, S Gagliardi, A Tubita, S Pandolfi, C Urso, L Borgognoni, J Wang, ... Oncogene 37 (19), 2601-2614, 2018 | 65 | 2018 |
| Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts A Gozzini, E Rovida, P Dello Sbarba, S Galimbert, V Santini Cancer research 63 (24), 8955-8961, 2003 | 64 | 2003 |
| The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines A Morandi, V Barbetti, M Riverso, P Dello Sbarba, E Rovida PloS one 6 (11), e27450, 2011 | 60 | 2011 |
| Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells S Giuntoli, E Rovida, A Gozzini, V Barbetti, MG Cipolleschi, M Olivotto, ... Stem Cells 25 (5), 1119-1125, 2007 | 59 | 2007 |
| Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway G Digiacomo, I Tusa, M Bacci, MG Cipolleschi, P Dello Sbarba, E Rovida Cell adhesion & migration 11 (4), 327-337, 2017 | 58 | 2017 |
| Low M r phosphotyrosine protein phosphatase associates and dephosphorylates p125 focal adhesion kinase, interfering with cell motility and spreading S Rigacci, E Rovida, PD Sbarba, A Berti Journal of Biological Chemistry 277 (44), 41631-41636, 2002 | 56 | 2002 |
| Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells V Barbetti, A Gozzini, E Rovida, A Morandi, E Spinelli, G Fossati, ... Oncogene 27 (12), 1767-1778, 2008 | 54 | 2008 |
| Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate S Giuntoli, M Tanturli, F Di Gesualdo, V Barbetti, E Rovida, PD Sbarba haematologica 96 (2), 204, 2011 | 53 | 2011 |
persio DELLO SBARBA在 unifi.it 的电子邮件经过验证
